ROBYN MCCUNE: Open Payments
NPI 1265892475 · ROGERS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,062 in 53 payments from 18 companies in 2025. Trend: 2023 $951 · 2024 $947 · 2025 $1,062
Food & beverage: $1,062
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 14 | $250 |
| ABBVIE INC. | 9 | $227 |
| AstraZeneca Pharmaceuticals LP | 2 | $152 |
| Amgen Inc. | 4 | $61 |
| Dynavax Technologies Corporation | 3 | $47 |
| Phathom Pharmaceuticals, Inc. | 4 | $47 |
| GlaxoSmithKline, LLC. | 3 | $46 |
| SANOFI PASTEUR INC. | 2 | $35 |
| Astellas Pharma US Inc | 2 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
Products named: NURTEC ODT, QULIPTA, FARXIGA, PREVNAR 20, UBRELVY, Heplisav-B, VOQUEZNA, TRELEGY ELLIPTA.
Industry payments across AR — which companies pay providers there.
